Home > services > Antibody Disovery Services

Antibody Disovery Services

Your partner for camelid-derived mAbs and single domain antibodies discovery and development.


High throughput development of TCR-mimic sdAbs


TCRm antibodies   

Traditional antibody therapy is limited to targeting cell surface antigens, leaving intracellular proteins, which are the majority of tumor-specific antigens, untouched. To address this issue, TCR-mimic antibodies have been developed. These antibodies recognize the peptide/MHC complexes on the surface of tumor cells, triggering a broad range of pharmacological pathways, including ADCC, CDC, ADCP, and apoptosis induction. TCR-minic antibodies can also be modified into a CAR structure to mediate cell immunity.


09f581d6d722376878f76793800b6c6.jpg


NBbiolab TCR-mimic sdAbs


1687934086807.jpg


Features of NBbiolab TCR-mimic sdAbs platform   

High-quality library construction based on yeast surface display technology.

Compatible with flow cytometry to precisely control screening parameters.

Enhanced antibody identifification through NGS analysis.

Extensive project experience ensures a high success rate.


TCRm英文2.png



Questions?

Contact us

Tel: +86 4008677715
+86 135 5108 6942
Address: SME Incubation Park, 319 Qingpi Avenue, Chengdu, China.
Email: service@nb-biolab.com
Our customer service representatives are available 24 hours a day, 7 days a week.

INFORMATION

Tel:+86 4008677715

E-mail:service@nb-biolab.com

Address:SME Incubation Park, 319 Qingpi Avenue, Chengdu, China.

Working time:9:00-18:00

Copyright © 2022 SICHUAN NB BIOLAB CO.,LTD For the record:蜀ICP备2022028448号-1Support:ANGOO